Colleen Cuffaro
Principal / East Coast
Since 2014
Colleen’s investment focus is early stage biopharmaceutical companies. Her interests lie in transformative medical technologies that deliver value to providers and patients alike. In her time at Canaan, Colleen helped launch the Canaan-Yale Fellowship program. Colleen previously worked as a chemist at Pharmaceutical Manufacturing and Research Services, Inc. She holds a Ph.D. in Cellular and Molecular Physiology from Yale University and a B.A. in Chemistry from the University of Pennsylvania.
Colleen in 5
Origins: Born & raised in Philadelphia
Travel: I love exploring new places, ideally by bicycle (Italy is #1 so far)
Family: Irish, Scottish & Italian descent
Interests: Swimming, biking, running, cooking, reading about cutting edge science
Accomplishments: 4X Ironman finisher
Investments
Current
Latest
FierceBiotech: Canaan-backed Comet uncloaks with $28.5M and biopharma vet De Graaf at the helm
STAT News: Arrakis' lofty goal: Kill cancer with pills that target RNA instead of proteins
Endpoints News: The Endpoints 11: A group of disruptive upstarts on a do-or-die mission to launch new meds
Business Insider: Meet the 30 biotech leaders under 40 who are shaping the future of medicine
Fierce Biotech: Canaan unveils $800 million fund for fresh wave of biotech bets
STAT: Biotech dreams of drugging the “undruggable”
GrowthCap: Top 40 Under 40 Growth Investors Of 2017
Genetic Engineering and Biotech News: Narrowing boardroom diversity divide
Colleen Cuffaro: Arrakis Therapeutics: Redefining the druggable target
Colleen in 5
Origins: Born & raised in Philadelphia
Travel: I love exploring new places, ideally by bicycle (Italy is #1 so far)
Family: Irish, Scottish & Italian descent
Interests: Swimming, biking, running, cooking, reading about cutting edge science
Accomplishments: 4X Ironman finisher